生物药剂学分类系统（BCS）、生物药剂学药物处置分类系统（BDDCS）及监管指南。 - Suppr

The BCS, BDDCS, and regulatory guidances.

作者信息

Chen Mei-Ling, Amidon Gordon L, Benet Leslie Z, Lennernas Hans, Yu Lawrence X

机构信息

Office of Pharmaceutical Science, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, Maryland 20993-0002, USA.

出版信息

Pharm Res. 2011 Jul;28(7):1774-8. doi: 10.1007/s11095-011-0438-1. Epub 2011 Apr 14.

DOI:10.1007/s11095-011-0438-1

PMID:21491148

Abstract

摘要

相似文献

The BCS, BDDCS, and regulatory guidances.

Pharm Res. 2011 Jul;28(7):1774-8. doi: 10.1007/s11095-011-0438-1. Epub 2011 Apr 14.

Impact of the US FDA "Biopharmaceutics Classification System" (BCS) Guidance on Global Drug Development.

Mol Pharm. 2017 Dec 4;14(12):4334-4338. doi: 10.1021/acs.molpharmaceut.7b00687. Epub 2017 Nov 7.

pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery.

Mol Pharm. 2012 May 7;9(5):1199-212. doi: 10.1021/mp2004912. Epub 2012 Apr 26.

BCS Biowaivers: Similarities and Differences Among EMA, FDA, and WHO Requirements.

AAPS J. 2016 May;18(3):612-8. doi: 10.1208/s12248-016-9877-2. Epub 2016 Mar 4.

Implementing the Biopharmaceutics Classification System in Drug Development: Reconciling Similarities, Differences, and Shared Challenges in the EMA and US-FDA-Recommended Approaches.

AAPS J. 2016 Jul;18(4):1039-46. doi: 10.1208/s12248-016-9915-0. Epub 2016 Apr 26.

The Biopharmaceutics Classification System (BCS) and the Biopharmaceutics Drug Disposition Classification System (BDDCS): Beyond guidelines.

Int J Pharm. 2019 Jul 20;566:264-281. doi: 10.1016/j.ijpharm.2019.05.041. Epub 2019 May 17.

The Discriminatory Power of the BCS-Based Biowaiver: A Retrospective With Focus on Essential Medicines.

J Pharm Sci. 2019 Sep;108(9):2824-2837. doi: 10.1016/j.xphs.2019.04.030. Epub 2019 May 3.

Current and evolving approaches for improving the oral permeability of BCS Class III or analogous molecules.

Drug Dev Ind Pharm. 2017 Feb;43(2):177-189. doi: 10.1080/03639045.2016.1269122. Epub 2016 Dec 20.

Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards.

Eur J Pharm Biopharm. 2000 Jul;50(1):3-12. doi: 10.1016/s0939-6411(00)00091-6.

The Effect of Excipients on the Permeability of BCS Class III Compounds and Implications for Biowaivers.

Pharm Res. 2016 Jan;33(1):167-76. doi: 10.1007/s11095-015-1773-4. Epub 2015 Aug 19.

引用本文的文献

Comparative Hydrophobicity, Solubility, and Metabolic Stability of 4(1)-Pyridones, 4(1)-Quinolones, and 9(10)-Acridones.

ACS Med Chem Lett. 2025 Mar 24;16(4):583-587. doi: 10.1021/acsmedchemlett.4c00618. eCollection 2025 Apr 10.

Parameterization of Physiologically Based Biopharmaceutics Models: Workshop Summary Report.

Mol Pharm. 2024 Aug 5;21(8):3697-3731. doi: 10.1021/acs.molpharmaceut.4c00526. Epub 2024 Jun 30.

Chemical Reactivity and Optical and Pharmacokinetics Studies of 14 Multikinase Inhibitors and Their Docking Interactions Toward ACK1 for Precision Oncology.

Front Chem. 2022 Apr 14;10:843642. doi: 10.3389/fchem.2022.843642. eCollection 2022.

An Overview on Dietary Polyphenols and Their Biopharmaceutical Classification System (BCS).

Int J Mol Sci. 2021 May 24;22(11):5514. doi: 10.3390/ijms22115514.

ICH Guideline for Biopharmaceutics Classification System-Based Biowaiver (M9): Toward Harmonization in Latin American Countries.

Pharmaceutics. 2021 Mar 10;13(3):363. doi: 10.3390/pharmaceutics13030363.

Classification of WHO Essential Oral Medicines for Children Applying a Provisional Pediatric Biopharmaceutics Classification System.

Pharmaceutics. 2019 Oct 31;11(11):567. doi: 10.3390/pharmaceutics11110567.

Can BDDCS illuminate targets in drug design?

Drug Discov Today. 2019 Dec;24(12):2299-2306. doi: 10.1016/j.drudis.2019.09.021. Epub 2019 Oct 1.

Drug Disposition Classification Systems in Discovery and Development: A Comparative Review of the BDDCS, ECCS and ECCCS Concepts.

Pharm Res. 2016 Nov;33(11):2583-93. doi: 10.1007/s11095-016-2001-6. Epub 2016 Jul 20.

BCS Biowaivers: Similarities and Differences Among EMA, FDA, and WHO Requirements.

AAPS J. 2016 May;18(3):612-8. doi: 10.1208/s12248-016-9877-2. Epub 2016 Mar 4.

Identifying 24 h variation in the pharmacokinetics of levofloxacin: a population pharmacokinetic approach.

Br J Clin Pharmacol. 2016 Feb;81(2):256-68. doi: 10.1111/bcp.12783. Epub 2015 Nov 25.

本文引用的文献

Computational systems chemical biology.

Methods Mol Biol. 2011;672:459-88. doi: 10.1007/978-1-60761-839-3_18.

High-permeability criterion for BCS classification: segmental/pH dependent permeability considerations.

Mol Pharm. 2010 Oct 4;7(5):1827-34. doi: 10.1021/mp100175a. Epub 2010 Sep 3.

The use of drug metabolism for prediction of intestinal permeability (dagger).

Mol Pharm. 2009 Jan-Feb;6(1):74-81. doi: 10.1021/mp8001864.

The use of BDDCS in classifying the permeability of marketed drugs.

Pharm Res. 2008 Mar;25(3):483-8. doi: 10.1007/s11095-007-9523-x. Epub 2008 Jan 31.

Intestinal permeability and its relevance for absorption and elimination.

Xenobiotica. 2007 Oct-Nov;37(10-11):1015-51. doi: 10.1080/00498250701704819.

Computational models to assign biopharmaceutics drug disposition classification from molecular structure.

Pharm Res. 2007 Dec;24(12):2249-62. doi: 10.1007/s11095-007-9435-9. Epub 2007 Sep 11.

Systems chemical biology.

Nat Chem Biol. 2007 Aug;3(8):447-50. doi: 10.1038/nchembio0807-447.

Biopharmaceutics classification of selected beta-blockers: solubility and permeability class membership.

Mol Pharm. 2007 Jul-Aug;4(4):608-14. doi: 10.1021/mp070028i. Epub 2007 Jul 18.

A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan.

Mol Pharm. 2006 Nov-Dec;3(6):631-43. doi: 10.1021/mp0600182.

The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension.

J Pharm Pharmacol. 2005 Mar;57(3):273-85. doi: 10.1211/0022357055263.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

The BCS, BDDCS, and regulatory guidances.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献